A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine
Clinical trial NCT04437433 · COMPLETED
Trial details
- NCT number
- NCT04437433
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2024-06-11
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.